Cardiology in Georgia

MagVenture is a privately owned Danish manufacturer of Transcranial Magnetic Stimulation (TMS) and Magnetic Peripheral Nerve Stimulation (mPNS) systems. The company has pioneered non-invasive TMS technology for over 30 years, serving clinicians, researchers, and diagnosticians globally. Products are designed, developed, produced, and quality-tested in Denmark and distributed through subsidiaries in the USA, Brazil, UK, China, and Germany, with presence in more than 70 countries. MagVenture TMS systems are FDA-cleared for treatment of Major Depressive Disorder (MDD) in adults and adolescents (15–21 years), Obsessive-Compulsive Disorder (OCD), anxiety-comorbid depression, and pain therapy. Systems also support diagnostic applications for stimulation of central and peripheral nervous systems, electrophysiological assessment via motor evoked potentials (MEP), and research in neuroscience, neurophysiology, neuroplasticity, and cognitive neuroscience. The company offers multiple therapy packages (R20, R30 standard and accelerated variants) with optional neuronavigation systems (Localite-Value and Localite-Premium), cooling systems, and specialized coils including the new T65 generation. Clinical support includes training, clinical protocols for standard and accelerated rTMS, and ongoing technical service.

RanD USA Inc. is a US-based subsidiary of RanD S.p.A., an Italian medical technology manufacturer specializing in hyperthermic perfusion systems. The company develops and markets the PERFORMER HT, an advanced system designed for hyperthermic perfusion therapy—a clinical technique combining controlled heat and perfusion for oncological and surgical applications. RanD operates as a distributor and support entity in North America, providing sales, technical support, and customer service for hyperthermic perfusion equipment. The parent company, established in Italy, manufactures the core technology and maintains regulatory compliance across international markets. RanD USA serves hospitals, surgical centers, and specialized oncology facilities seeking advanced thermal perfusion capabilities. The company emphasizes innovation in medical technology to achieve significant patient health improvements. Contact is available through dedicated US support channels, including direct phone access and email for sales inquiries and technical assistance.

Gerresheimer is a global pharmaceutical packaging and drug delivery systems manufacturer with operations in over 40 production sites across Europe, Americas, and Asia. The company serves pharmaceutical, diagnostic, and medical device manufacturers with integrated solutions spanning concept development through final product manufacturing. Primary product lines include pharmaceutical primary packaging (glass and plastic containers), prefilled syringes, injectable drug delivery systems, diagnostic and medical products, and cosmetic packaging. The company manufactures PCR test components, diagnostic single-use articles, and custom combination products. Gerresheimer operates with quality as a core philosophy, meeting stringent regulatory requirements and hygiene standards. The organization employs approximately 13,600 staff and is committed to sustainability targets including 100% renewable energy procurement by 2030 and 50% CO2 emission reduction. The company participates in major pharmaceutical and biotech conferences and maintains a strong focus on innovative solutions for biopharmaceuticals and patient adherence support systems.

Elekta AB is a global leader in precision cancer care, specializing in radiotherapy and radiosurgery systems for oncology treatment. With over 50 years of experience, the company develops advanced solutions for adaptive radiotherapy—a precision treatment approach that adjusts to patient anatomy changes during therapy. Elekta's product portfolio includes linear accelerators for external beam radiotherapy, the Leksell Gamma Knife for stereotactic radiosurgery, and integrated imaging and software systems for treatment planning and guidance. The company serves cancer centers and hospitals worldwide, addressing multiple tumor types including head and neck, breast, prostate, brain, gynecological, kidney, and pancreatic cancers. Elekta's adaptive radiotherapy platform combines daily imaging, AI-assisted planning, and real-time treatment adjustment to optimize dose delivery while protecting healthy tissue. The company supports clinical workflows with comprehensive software solutions for treatment planning, image guidance, and outcome tracking. Elekta maintains a strong commitment to clinical evidence generation and supports leading oncology institutions globally. As a publicly traded company headquartered in Sweden, Elekta operates a global infrastructure including manufacturing, service centers, and training facilities. The organization emphasizes precision medicine innovation and advancing radiotherapy as a standard of care across diverse patient populations and healthcare settings.

Digirad is a healthcare solutions provider headquartered in Suwanee, Georgia, specializing in diagnostic imaging and mobile healthcare services. Founded in the mid-1990s, the company pioneered solid-state nuclear medicine detector technology and achieved a major milestone in 2000 with the first commercially performed solid-state nuclear medicine scan. Digirad operates nationwide, delivering on-demand diagnostic services across four key segments: diagnostic services, mobile healthcare, diagnostic imaging, and medical device sales and services. The company serves a diverse customer base ranging from small practices to large hospital systems, offering nuclear and ultrasound imaging, contract-based diagnostic imaging, and solid-state nuclear imaging systems. Digirad emphasizes point-of-care convenience and scalable solutions that enhance operational efficiency for healthcare providers.

Avanos Medical, Inc. is a specialized medical device manufacturer focused on two core therapeutic areas: enteral feeding solutions and pain management & recovery. The company develops and markets a comprehensive portfolio of specialty nutrition delivery systems for neonates, pediatric, adult, and geriatric patients, along with non-opioid pain management and post-operative recovery solutions. Key product lines include MIC-KEY® low-profile feeding tubes, CORTRAK® NG tube guidance systems, NEOMED® neonatal solutions, GAME READY® cryo-compression therapy, COOLIEF® cooled radiofrequency systems, and ON-Q® elastomeric infusion pumps. The ON-Q® and ambIT® infusion pumps are recognized under the CMS NOPAIN Act (effective January 1, 2025) as qualifying non-opioid pain management solutions eligible for separate reimbursement. Avanos serves critical care physicians, anesthesiologists, interventional pain specialists, orthopedic surgeons, sports medicine practitioners, neonatologists, and NICU professionals. The company operates a direct customer portal for online ordering, maintains a 24/7 nurse hotline for surgical pain product support, and provides sales representation across North America. Avanos markets solutions emphasizing improved patient outcomes, reduced opioid dependency, and clinical efficacy in both acute surgical settings and chronic pain management.

Alliance Spine and Pain Centers is a leading interventional pain management practice with the largest network of clinics across Georgia (Atlanta, Augusta, Austell, and 20+ additional locations). The practice specializes in non-surgical, minimally invasive treatments for chronic pain conditions affecting the spine, neck, back, joints, and extremities. Clinical offerings include advanced interventional procedures such as spinal cord stimulation, epidural steroid injections, radiofrequency ablation, nerve blocks, medial branch blocks, kyphoplasty, and vertebroplasty. The practice also provides regenerative medicine therapies including platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and alpha-2-macroglobulin treatments. Additional services address diabetic neuropathy, sciatica, radiculopathy, spinal stenosis, and osteoporosis-related pain. All providers hold Joint Commission accreditation and work with most major insurance carriers. The multidisciplinary team includes physicians, physician assistants, nurse practitioners, and behavioral health specialists focused on opioid-reduction strategies and root-cause pain management.